antimony has been researched along with Recrudescence in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (29.17) | 18.7374 |
1990's | 10 (41.67) | 18.2507 |
2000's | 6 (25.00) | 29.6817 |
2010's | 1 (4.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aragão, MT; Braz, JM; da Silva, ÂM; de Almeida, RP; de Jesus, AR; de Moura, TR; de Oliveira, FA; Santos, LF; Santos, ML; Santos, PL | 1 |
Coffman, RL; Freeman, S; Kaplan, G; Lu, CM; Mauze, S; Moreira, AL; Murray, HW | 1 |
DAWOOD, MM; HALAWANI, A | 1 |
Laguna, F | 1 |
Aronson, N; Lesho, EP; Neafie, R; Wortmann, G | 1 |
Ammari, L; Belhadj, S; Ben Chaabene, T; Chaker, E; Kanoun, F; Kilani, B; Tiouiri, H; Toumi, A | 1 |
Fisher, BK; Schewach-Millet, M; Semah, D | 1 |
Bienzle, U; Reindke, B; Wittermann, C | 1 |
Boer, C; Davidson, R; de Jong, J; de Wilde, E; Seaman, J; Sondorp, E; Wilkinson, R | 1 |
Cortes, E; de Otero, J; Gasser, I; Ocaña, I; Pahissa, A; Ribera, E | 1 |
Buscaylet, S; Durand, JM; Kaplanski, G; Penot-Ragon, C; Soubeyrand, J | 1 |
Alcázar, R; Benezet, J; De la Torre, M; Ortega-Carnicer, J | 1 |
Slappendel, RJ; Teske, E | 1 |
da Costa, SC; Mattos, M; Oliveira-Neto, MP; Pirmez, C; Schubach, A | 1 |
Chantraine, JM; Dresse, MF; Gillet, P; Hoyoux, C; Marguglio, A; Thiry, A | 1 |
Briner, V; Heer, K; Pfister, D | 1 |
Corzo, JE; de la Rosa, R; Delgado, J; González-Moreno, MP; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
Camacho, EL; de Godoy, JM; de Godoy, MF; Paiva, EV; Valente, A | 1 |
Berenguer, J; Cosín, J; López, JC; Miralles, P; Padilla, B | 1 |
Meira, JA | 1 |
Enriquez, A; García Aguado, C; Gazapo, E; González Lahoz, JM; Laguna, F; Martínez, P; Puente, S | 1 |
Santrich, C; Saravia, NG; Valderrama, L; Weigle, KA | 1 |
Bhattacharyya, S; Khan, KP; Mukherjee, AM | 1 |
Kern, F; Pedersen, JK | 1 |
2 review(s) available for antimony and Recrudescence
Article | Year |
---|---|
Treatment of leishmaniasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiprotozoal Agents; Drug Therapy, Combination; HIV Seropositivity; Humans; Interferon-gamma; Leishmaniasis, Visceral; Liposomes; Phospholipids; Recurrence | 2003 |
Nonhealing skin lesions in a sailor and a journalist returning from Iraq.
Topics: Adult; Antimony; Diagnosis, Differential; Female; Humans; Iraq; Journalism; Leishmaniasis, Cutaneous; Male; Military Medicine; Military Personnel; Recurrence; Warfare | 2005 |
3 trial(s) available for antimony and Recrudescence
Article | Year |
---|---|
Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions.
Topics: Adolescent; Adult; Aged; Amebicides; Amphotericin B; Animals; Anti-Bacterial Agents; Antimony; Child; Child, Preschool; Drug Administration Schedule; Drug Carriers; Female; Humans; Infant; Leishmania donovani; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Lymph Nodes; Male; Middle Aged; Paromomycin; Recurrence; Spleen; Sudan | 1995 |
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
Topics: Adult; Aged; Allopurinol; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Data Interpretation, Statistical; Female; Follow-Up Studies; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Multivariate Analysis; Organometallic Compounds; Recurrence; Retrospective Studies; Time Factors | 1996 |
The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial.
Topics: Animals; Antimony; Antiprotozoal Agents; Disease-Free Survival; Dog Diseases; Dogs; Female; Injections, Intravenous; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Remission Induction; Treatment Outcome | 1997 |
19 other study(ies) available for antimony and Recrudescence
Article | Year |
---|---|
Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages.
Topics: Adult; Amphotericin B; Animals; Antimony; Cytokines; Drug Resistance; Drug Tolerance; Humans; Immune Tolerance; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Macrophages; Male; Mice; Middle Aged; Nitric Oxide; Nitrites; Recurrence; Spleen | 2016 |
Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.
Topics: Animals; Antimony; Granuloma; Immunotherapy; Interleukin-10; Interleukin-12; Interleukin-4; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Receptors, Interleukin; Receptors, Interleukin-10; Recurrence | 2002 |
Evaluation of the treatment of bilharziasis with fouadin, stibophen and anthiomaline with special reference to the apparent cure-rates and relapse-rates.
Topics: Antimony; Benzenesulfonates; Chronic Disease; Organometallic Compounds; Recurrence; Schistosomiasis | 1953 |
[Demographic, clinical and therapeutic features of adult visceral leishmaniasis at the Rabta hospital in Tunis (tunisia) from 1983 to 2002].
Topics: Adult; Amphotericin B; Anemia; Animals; Antimony; Antiprotozoal Agents; Fever; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Splenomegaly; Treatment Outcome; Tunisia | 2007 |
Leishmaniasis recidivans treated with sodium stibogluconate.
Topics: Adult; Anti-Bacterial Agents; Antimony; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence | 1981 |
[Diagnosis and therapy of visceral leishmaniasis].
Topics: Antimony; Child, Preschool; Humans; Leishmaniasis, Visceral; Pentamidine; Recurrence | 1980 |
Antimony/interferon-gamma combination in the treatment of visceral leishmaniasis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antimony; CD4-CD8 Ratio; Humans; Interferon-gamma; Leishmaniasis, Visceral; Male; Meglumine; Recurrence | 1996 |
Pentavalent antimonial-induced torsade de pointes.
Topics: Aged; Anti-Arrhythmia Agents; Antimony; Antiprotozoal Agents; Electrocardiography; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Torsades de Pointes | 1997 |
Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil--an area of Leishmania (V.) braziliensis transmission.
Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Brazil; Costs and Cost Analysis; Female; Follow-Up Studies; Humans; Injections, Intralesional; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Recurrence; Remission Induction; Skin Ulcer; Treatment Outcome; Wound Healing | 1997 |
[Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma].
Topics: Amphotericin B; Antifungal Agents; Antimony; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Child; Chronic Disease; Humans; Interferon-gamma; Leishmaniasis, Visceral; Liposomes; Lung Neoplasms; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osteosarcoma; Recurrence; Spinal Neoplasms | 1998 |
Revival of tetracyclines--in the treatment of visceral leishmaniasis?
Topics: Adult; Antimony; Doxycycline; Humans; Leishmaniasis, Visceral; Male; Opportunistic Infections; Recurrence; Tetracyclines; Treatment Outcome | 1999 |
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
Topics: Adult; Amylases; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Creatinine; Female; HIV Infections; HIV-1; Humans; Leishmania infantum; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence; Retrospective Studies; Vomiting | 1999 |
Lymphoscintigraphic evaluation in patients after erysipelas.
Topics: Adult; Aged; Antimony; Erysipelas; Female; Humans; Lymphedema; Lymphoscintigraphy; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Technetium Tc 99m Sulfur Colloid | 2000 |
[Visceral leishmaniasis associated with human immunodeficiency virus infection (reply)].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Administration Schedule; HIV Infections; Humans; Immunocompromised Host; Leishmaniasis, Visceral; Prospective Studies; Recurrence; Spain; Viral Load | 2002 |
[Clinical evolution of schistosomiasia mansonic. Personal observations].
Topics: Adult; Antimony; Biopsy; Diagnosis, Differential; Female; Humans; Male; Recurrence; Schistosoma mansoni; Schistosomiasis | 1977 |
[Visceral leishmaniasis: a study of 15 cases].
Topics: Age Factors; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Serologic Tests; Sex Factors; Spain | 1992 |
Recurrences of tegumentary leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Child; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence | 1985 |
A relapse case of post-kala-azar dermal leishmaniasis (P.K.D.L.).
Topics: Antimony; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Recurrence; Skin Diseases, Infectious | 1973 |
Leishmaniasis in the United States. A report of ten cases in military personnel.
Topics: Adolescent; Adult; Antibodies; Antimony; Humans; Injections, Intramuscular; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Male; Military Medicine; Panama; Recurrence; United States | 1973 |